These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14987879)

  • 1. Specific antitumour vaccine for renal cancer.
    Fishman M; Antonia S
    Lancet; 2004 Feb; 363(9409):583-4. PubMed ID: 14987879
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial.
    Jocham D; Richter A; Hoffmann L; Iwig K; Fahlenkamp D; Zakrzewski G; Schmitt E; Dannenberg T; Lehmacher W; von Wietersheim J; Doehn C
    Lancet; 2004 Feb; 363(9409):594-9. PubMed ID: 14987883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal-cell carcinoma: vaccination and risk of tumour progression.
    Kommu S
    Lancet; 2004 May; 363(9420):1557; author reply 1557. PubMed ID: 15135619
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer.
    Dillman RO; Beutel LD; Cornforth AN; Nayak SK
    Cancer Biother Radiopharm; 2000 Apr; 15(2):161-8. PubMed ID: 10803321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 6. TroVax(®) vaccine therapy for renal cell carcinoma.
    Zhang RT; Bines SD; Ruby C; Kaufman HL
    Immunotherapy; 2012 Jan; 4(1):27-42. PubMed ID: 22149999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
    Lam JS; Leppert JT; Belldegrun AS; Figlin RA
    BJU Int; 2005 Sep; 96(4):483-8. PubMed ID: 16104896
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular vaccine therapies for cancer.
    Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
    Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination therapy of localized and locally-advanced renal-cell cancer using preoperative arterial embolization].
    Karelin MI; Atroshchenko AV; Shkol'nik MI; Leonenkov RV; Belov AD; Kharitonov MV
    Vopr Onkol; 2008; 54(1):95-7. PubMed ID: 18416067
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines for colorectal cancer and renal cell carcinoma.
    Kabaker K; Shell K; Kaufman HL
    Cancer J; 2011; 17(5):283-93. PubMed ID: 21952277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor cell vaccination for treatment of renal cell carcinoma].
    Kriegmair M; Oberneder R
    Urologe A; 1995 May; 34(3):204-7. PubMed ID: 7610513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Bellmunt J; Ribas A
    Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Clark PE
    Eur Urol; 2009 Jun; 55(6):1343-4. PubMed ID: 19201523
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer.
    Simons JW
    Hinyokika Kiyo; 1997 Nov; 43(11):821-2. PubMed ID: 9436029
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines in renal cell carcinoma.
    Kübler H; Vieweg J
    Semin Oncol; 2006 Oct; 33(5):614-24. PubMed ID: 17045091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of renal cell carcinoma with interferons].
    Oya M
    Nihon Rinsho; 2006 Jul; 64(7):1281-5. PubMed ID: 16838645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer.
    Galligioni E; Francini M; Quaia M; Carbone A; Spada A; Sacco C; Favaro D; Santarosa M; Carmignani G; Di Donna D
    Ann N Y Acad Sci; 1993 Aug; 690():367-9. PubMed ID: 8368758
    [No Abstract]   [Full Text] [Related]  

  • 18. A vaccine in renal cell carcinoma: are we nearing reality?
    Bedke J; Gouttefangeas C; Kruck S; Stenzl A
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1503-5. PubMed ID: 23253216
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for metastatic renal cell carcinoma.
    McDermott DF; Rini BI
    BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
    [No Abstract]   [Full Text] [Related]  

  • 20. IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
    Rausch S; Kruck S; Stenzl A; Bedke J
    Future Oncol; 2014 May; 10(6):937-48. PubMed ID: 24941980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.